1. THU0616 Elevated thyroid stimulating hormone as a potential biomarker for rheumatic immune-related adverse events following pd-1 inhibitor therapy. (12th June 2018) Authors: Liew, D.F.L.; Leung, J.L.Y.; McMaster, C.; Djukiadmodjo, F.; Liu, B.; Cebon, J.; Frauman, A.G.; Buchanan, R.R.C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗